RT @AaronBosterMD: A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine,…
5 followers
333 followers
A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS https://t.co/ubGqZB1j3A
1,014 followers
Urgent need for novel neuroreparative & neuroprotective immune modulating therapies. Phase1b study: assess safety & tolerability of ascending #liothyronine doses in indivs w/#MS; assess effect on clinical disability & #HRQOL. @Calabre04804429 @
1,066 followers
Ty, @MStranslate 🙏😘@SammyJoLDN